There's a Nature paper, 2026 just came out that looked at cardiovascular disease and cancer mortality and all these different metrics that they did MRIs of people, and the people who had the higher thymic scores had less mortality across every single one of these conditions
The ideal candidates for GLP-1 therapy during menopause are those with obesity, insulin resistance, or persistent weight gain despite healthy habits
These medications: Decrease hepatic triglyceride accumulation by reducing de novo lipogenesis 19 Lower the expression of SREBP-1c and SCD-1, key regulators in fat production 19 Increase PPAR- expression, enhancing the breakdown of fatty acids 19 Reduce inflammation and oxidative stress that drive liver damage 19 Studies show these liver benefits arent entirely dependent on weight loss
Support for the immune system Zinc and selenium contribute to the protection of cells from oxidative stress and normal immune function
Photo: Getty Images June 2, 2026 Results of an American College of Radiology-managed retrospective study involving 110,000 women presented at the 2026 ASCO Annual Meeting, shows that those who took GLP-1 medications were up to 35% less likely to develop breast cancer than those who did not take GLP-1 drugs
